BeOne Medicines AG (ONC) Stock Overview
Explore BeOne Medicines AG’s financial performance, market position, analyst ratings, and future outlook.
BeOne Medicines AG (ONC)
Key Financials
Key Financials
Market Cap
44.9B
P/E Ratio
6.49
EPS (TTM)
$5.68
ROE
0.18%
ONC Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of BeOne Medicines AG (NASDAQ: ONC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, BeOne Medicines AG's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ONC on the NASDAQ shows an RSI of 70.08, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $361.60 for the NASDAQ listing.
Key metrics behind BeOne Medicines AG's NASDAQ-traded stock include a P/E ratio of 6.49 and a market capitalization of 44.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ONC on the NASDAQ.